Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock
Author(s) -
Frank Bloos,
Evelyn Trips,
Axel Nierhaus,
Josef Briegel,
Daren K. Heyland,
Ulrich Jaschinski,
Onnen Moerer,
A. Weyland,
Gernot Marx,
Matthias Gründling,
Stefan Kluge,
Inès Kaufmann,
K. Ott,
Michael Quintel,
Florian Jelschen,
Patrick Meybohm,
Sibylle Rademacher,
Andreas MeierHellmann,
Stefan Utzolino,
Udo X. Kaisers,
Christian Putensen,
Gunnar Elke,
Maximilian Ragaller,
Herwig Gerlach,
Katrin Ludewig,
Michael Kiehntopf,
Holger Bogatsch,
Christoph Engel,
Frank M. Brunkhorst,
Markus Loeffler,
Konrad Reinhart
Publication year - 2016
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2016.2514
Subject(s) - medicine , procalcitonin , septic shock , sepsis , selenium , intensive care medicine , shock (circulatory) , materials science , metallurgy
High-dose intravenous administration of sodium selenite has been proposed to improve outcome in sepsis by attenuating oxidative stress. Procalcitonin-guided antimicrobial therapy may hasten the diagnosis of sepsis, but effect on outcome is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom